XML 48 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Information and Concentration of Business Risk, Segment Information (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 31, 2017
Jul. 19, 2017
Jun. 30, 2017
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Segment
Jun. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Segment Information [Abstract]              
Number of reportable segments | Segment         2    
Percentage ownership before IPO         100.00%    
Commercial Revenue [Abstract]              
SPINRAZA royalties     $ 22,366 $ 0 $ 27,577 $ 0  
Licensing and other royalty revenue     557 16,015 4,103 17,675  
Total commercial revenue     22,923 16,015 31,680 17,675  
R&D revenue under collaborative agreements     81,229 22,455 182,776 57,670  
Total segment revenue     104,152 38,470 214,456 75,345  
Total operating expenses     105,823 87,397 202,138 178,922  
Income (loss) from operations     (1,671) (48,927) 12,318 (103,577)  
Total assets     1,090,831   1,090,831   $ 912,467
Operating Segments [Member] | Ionis Core [Member]              
Commercial Revenue [Abstract]              
SPINRAZA royalties     22,366   27,577    
Licensing and other royalty revenue     557 16,015 4,103 17,675  
Total commercial revenue     22,923   31,680    
R&D revenue under collaborative agreements     70,031 22,455 213,457 57,670  
Total segment revenue     92,954 38,470 245,137 75,345  
Total operating expenses     83,381 72,622 161,733 148,135  
Income (loss) from operations     9,573 (34,152) 83,405 (72,790)  
Total assets     1,227,050   1,227,050   1,067,770
Operating Segments [Member] | Akcea Therapeutics [Member]              
Commercial Revenue [Abstract]              
SPINRAZA royalties     0   0    
Licensing and other royalty revenue     0 0 0 0  
Total commercial revenue     0   0    
R&D revenue under collaborative agreements     14,128 0 23,725 0  
Total segment revenue     14,128 0 23,725 0  
Total operating expenses     25,402 14,805 94,872 30,847  
Income (loss) from operations     (11,274) (14,805) (71,147) (30,847)  
Total assets     124,104   124,104   10,684
Elimination of Intercompany Activity [Member]              
Commercial Revenue [Abstract]              
SPINRAZA royalties     0   0    
Licensing and other royalty revenue     0 0 0 0  
Total commercial revenue     0   0    
R&D revenue under collaborative agreements     (2,930) 0 (54,406) 0  
Total segment revenue     (2,930) 0 (54,406) 0  
Total operating expenses     (2,960) (30) (54,467) (60)  
Income (loss) from operations     30 $ 30 60 $ 60  
Total assets     $ (260,323)   $ (260,323)   $ (165,987)
Subsequent Event [Member]              
Segment Information [Abstract]              
Percentage ownership after IPO 68.00% 68.00%